Literature DB >> 8450993

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

D L Bachman1, P A Wolf, R T Linn, J E Knoefel, J L Cobb, A J Belanger, L R White, R B D'Agostino.   

Abstract

OBJECTIVE: To determine the incidence of dementia and Alzheimer's disease (AD) in a general population sample.
BACKGROUND: Utilizing subjects in the Framingham Study cohort determined to be free of dementia in 1976 to 1978, or on biennial examination 17 in 1982, all new cases of dementia arising in this cohort over a maximum of 10 years of follow-up were ascertained.
METHODS: On biennial examination 14/15, a screening neuropsychologic examination was administered to 2,117 subjects, and cases of probable prevalent dementia were identified. Beginning on examination 17 and on all successive biennial examinations, a Mini-Mental State Examination was administered. Subjects previously free of dementia and falling below age-education levels were evaluated by a neurologist and neuropsychologist to determine if dementia was present and to ascertain the dementia type using standard criteria.
RESULTS: Five-year incidence of dementia increased with age, doubling in successive 5-year age groups. Dementia incidence rose from 7.0 per 1,000 at ages 65 to 69 to 118.0 per 1,000 at ages 85 to 89 for men and women combined. Incidence of probable AD also doubled with successive quinquennia from 3.5 at ages 65 to 69 to 72.8 per 1,000 at ages 85 to 89 years. Incidence of dementia and of probable AD did not level off with age and was not different in men and women.
CONCLUSIONS: In a general population sample, we determined incidence of dementia and of probable AD and will use these incident cases for study of precursors and natural history in this elderly cohort, which has been under close surveillance for over 40 years.

Entities:  

Mesh:

Year:  1993        PMID: 8450993     DOI: 10.1212/wnl.43.3_part_1.515

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  79 in total

1.  Effects of the Medicare Alzheimer's Disease Demonstration on nursing home entry.

Authors:  R Miller; R Newcomer; P Fox
Journal:  Health Serv Res       Date:  1999-08       Impact factor: 3.402

Review 2.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

3.  Incidence of dementia and cognitive impairment, not dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

4.  Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Fabrizio Vecchio; Roberta Lizio; Michela Pievani; Geroldi Cristina; Claudia Fracassi; Fabrizio Vernieri; Guido Rodriguez; Flavio Nobili; Raffaele Ferri; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2010-12-22       Impact factor: 5.038

Review 5.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

6.  Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: the 90+ study.

Authors:  Kristin Kahle-Wrobleski; Maria M Corrada; Bixia Li; Claudia H Kawas
Journal:  J Am Geriatr Soc       Date:  2007-02       Impact factor: 5.562

Review 7.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

8.  Incidence rates of dementia, Alzheimer disease, and vascular dementia in the Japanese American population in Seattle, WA: the Kame Project.

Authors:  Amy R Borenstein; Yougui Wu; James D Bowen; Wayne C McCormick; Jay Uomoto; Susan M McCurry; Gerard D Schellenberg; Eric B Larson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

Review 9.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

10.  Enzymatic antioxidant balance and cognitive decline in aging--the EVA study.

Authors:  Claudine Berr; Marie-Jeanne Richard; Véronique Gourlet; Catherine Garrel; Alain Favier
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.